Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I can't wait for the next earnings news
Good work. Good DD
Nice finding, I like to see what they really do
12 mil n revs in 18 months and thats without the 4 Q #'s
WOOOHOOO
I saw it and I am really think we have a big winner here
so thats the reason for the increased revenue.
PATENT INFORMATION
In response to the mountain of scientific, clinical, and epidemiologic research, Genelink sought to make the utility in personalized medicine accessible to the average person by combining the bioinformatic value of DNA analysis with the pharmacological value of nutraceuticals to deliver a treatment regimen that seeks to maintain well-being, rather than just treating disease. GeneLink’s highly credentialed scientific group is comprised of leading scientists and researchers in the fields of biotechnology, genomics, molecular biology, chemistry, medicine, clinical laboratory medicine and nutritional sciences. As a group, they have over 500 peer reviewed publications and abstracts, numerous awards, dozens of patents and distinguished careers with some of the world’s foremost public and private biosciences corporations as well as universities. GeneLink has been granted multiple patents for the application of their SNP profiles for assessing oxidative stress for a therapeutic skin health regimen linked to DNA-based skin health assessment (U.S. and Australian patents for "Kits and Methods for Assessing Skin Health" (U.S. Patent number 7,211,383; Australian patents 2003275038 and 2002309543). Genelink has also filed multiple patents for: Kits and Methods for Assessing Oxidative Stress; Kits and Methods for Assessing Cardiovascular Health; Kits and Methods for Assessing Bone Health; Kits and Methods for Assessing Coenzyme Q Reducing Status to support their scientific valifity and business model. GeneLink’s developmental pipeline incorporates important Medical and Pharmacogenomic research areas such as genetic assessments for early the detection of Alzheimer’s and Dementia, Cardiovascular Disease, Metabolic Syndrome and innovative methods for DNA collection.
yes, nice video, I can see it 1000 times
I think that was a fluke today.. MM manipulation
dunno if we get anymore that cheep
Revenues & Audits
Since the launch of Genewize in the second half of 2008, Genelink has had about $12 million in revenue. This amazing change in revenue demonstrates the efficacy of the MLM platform compared to a corporate sales approach, and also validates the success of the Genelink SNP assesment concept. In fact, GNLK was ranked number 92 on Technology Fast 500TM, Deloitte LLP’s ranking of 500 of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Rankings are based on percentage of fiscal year growth during the five year period from 2004-2008. GeneLink experienced 1,991 percent growth during this period.
The sales speak for themselves. Through its subsidiary Genewize, Genelink has finally validated the expansion of its concept. With its innovative genetic profiles to help the company create and deliver more effective products — personalized wellness and “quality of life” products tailored to their customer’s individual needs. The science is solidly based on the state of the art understanding of genetics, allowing the consumer and/or their health care provider to determine what vitamin/nutritional supplements, skin-care products, and health care or weight loss regimens are best for their individual needs.
it looks like the financial will be good anyway
department of defense, sweet ,nice finding
I was so close to buying when it hit .11 today. Just as i was placing the order the ask upticked and i could not get filled. Would have been a nice gain.
Yes, it's getting better.
with new CEO the things are getting better
http://biz.yahoo.com/e/100201/gnlk.ob8-k.html
Had to kick myself in the head for not picking up more at the dip. If there is more dip tomorrow, won't ever miss it.
I just found out that there 2009 revenue far exceeded thier 2008 revenue. And that they expect the same for 2010.
Why the huge dip today? what was going on?
it looks there a quite good support at that level
I hope not so big, i want to load too
me too, but i think there will be a gap up tomorrow
I will be right there with you my friend. From the looks of the chart though i dont think that will happen anytime soon.
The Volume surged over the last few days and i think that's what's involving the MM's if not; it's long time holds that haven't seen the stock this high of a level. So we shall see.
first step and target is to reach 0.5
If it dips below .12 i will be loading up.
me too, i can watch them for hours. thinking my investments
Yes, you should read also
I was watching and watching the videos
this is a million dollar company and we are at 0.13 ,....
Yes, i think it should be nice
I should find soem links to other video
Did you guys see that they had 20+ patents including On The DNA Collection System, that's something. Too much great potentials.
Yeah that was a nice Vid.
Personalization Via DNA, the next HOT thing for sure!!!
yes, really great, some of them I already saw
really good, youtube is helping a lot , I see
I have more video
Wow!!! Did not know this. I am really liking the potential of the company.
did you see these video?
GeneLink innovations led the company to develop a proprietary mass customization system for nutritional supplements and skin care product delivery. In 2005, GeneLink introduced DNA UltraCustom™ - the first scientifically proven anti-aging skin-care products for consumers based on their individual Skin-DNA profile.
o.5 is also my target, ii looks like is really possible
ehheeh, yes, this is my target..... sweet
Dang!!! That is quite a target. I would love it if it hits that.
Followers
|
20
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
573
|
Created
|
01/14/05
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |